Assignee
MEDIGENE AG
DE·32 granted patents·17 pending applications·971 citations·filing 1997–2019
Top patents by PatentIndex Score
49 records- 0196US7968340B2Structural protein of adeno-associated virus with modified antigenicity, its production and its useMEDIGENE AG·Filed 2009·Granted Jun 28, 2011·88 cites·8 claims
- 0294US6207453B1Recombinant AAV vector-based transduction system and use of sameMEDIGENE AG·Filed 1997·Granted Mar 27, 2001·299 cites·13 claims
- 0393US9624274B2Mutated structural protein of a parvovirusMEDIGENE AG·Filed 2012·Granted Apr 18, 2017·79 cites·16 claims
- 0493US7252997B1Structural protein of adeno-associated virus with modified antigenicity, its production and its useMEDIGENE AG·Filed 2000·Granted Aug 7, 2007·66 cites·8 claims
- 0593US7001765B2Adeno-associated virus vector for boosting immunogenicity of cellsMEDIGENE AG·Filed 2003·Granted Feb 21, 2006·61 cites·11 claims
- 0692US6846665B1Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicamentMEDIGENE AG·Filed 2000·Granted Jan 25, 2005·51 cites·27 claims
- 0791US7556965B2Structural protein of adeno-associated virus with modified antigenicity, its production and its useMEDIGENE AG·Filed 2007·Granted Jul 7, 2009·28 cites·8 claims
- 0888US7285381B1Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the sameMEDIGENE AG·Filed 2000·Granted Oct 23, 2007·30 cites·28 claims
- 0987US9060998B2Use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skinMEDIGENE AG·Filed 2013·Granted Jun 23, 2015·20 cites·15 claims
- 1086US6649167B2Papillomavirus truncated L1 protein and fusion protein constructsMEDIGENE AG·Filed 2001·Granted Nov 18, 2003·29 cites·13 claims
- 1185US7314912B1AAv scleroprotein, production and use thereofMEDIGENE AG·Filed 1999·Granted Jan 1, 2008·92 cites·15 claims
- 1281US9238021B2Method of producing a cationic liposomal preparation comprising a lipophilic compoundMEDIGENE AG·Filed 2014·Granted Jan 19, 2016·2 cites·26 claims
- 1376US7858662B2Medicament for the treatment of viral skin and tumour diseasesMEDIGENE AG·Filed 2002·Granted Dec 28, 2010·9 cites·25 claims
- 1476US7794747B2Method of producing a cationic liposomal preparation comprising a lipophilic compoundMEDIGENE AG·Filed 2004·Granted Sep 14, 2010·6 cites·22 claims
- 1576US7618452B2Artificially produced, three-dimensional muscle tissueMEDIGENE AG·Filed 2001·Granted Nov 17, 2009·6 cites·15 claims
- 1676US7494658B2Papilloma virus truncated L1 protein and fusion protein constructsMEDIGENE AG·Filed 2005·Granted Feb 24, 2009·2 cites·10 claims
- 1776US7182947B2Papillomavirus truncated L1 protein and fusion protein constructsMEDIGENE AG·Filed 2003·Granted Feb 27, 2007·7 cites·15 claims
- 1875US6838272B2Filtration process for separating virusesMEDIGENE AG·Filed 2002·Granted Jan 4, 2005·4 cites·38 claims
- 1975US6352696B1Papillomavirus truncated L1 protein and fusion protein constructsMEDIGENE AG·Filed 2001·Granted Mar 5, 2002·29 cites·13 claims
- 2070US6479273B1Filtration method for separating virusesMEDIGENE AG·Filed 1998·Granted Nov 12, 2002·25 cites·38 claims
- 2169US6440742B1Recombinant AAV vector-based transduction system and use of sameMEDIGENE AG·Filed 2001·Granted Aug 27, 2002·4 cites·7 claims
- 2268US2011052617A1Aav scleroprotein, production and use thereofMEDIGENE AG·Filed 2009·Application pending·0 cites
- 2366US7078543B2Methods for producing oxirane carboxylic acids and derivatives thereofMEDIGENE AG·Filed 2002·Granted Jul 18, 2006·7 cites·13 claims
- 2466US6838084B1Cytotoxic T-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapyMEDIGENE AG·Filed 2000·Granted Jan 4, 2005·5 cites·1 claims
- 2566US2020191788A1Mutated parvovirus structural proteins as vaccinesMEDIGENE AG·Filed 2019·Application pending·0 cites
- 2661US2007238684A1AAV scleroprotein, production and use thereofMEDIGENE AG·Filed 2006·Application pending·0 cites
- 2759US2020054552A1Medicament for the treatment of viral skin and tumour diseasesMEDIGENE AG·Filed 2019·Application pending·0 cites
- 2859US2010178243A1Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier systemMEDIGENE AG·Filed 2009·Application pending·0 cites
- 2958US10822378B2Mutated structural protein of a parvovirusMEDIGENE AG·Filed 2017·Granted Nov 3, 2020·0 cites·16 claims
- 3057US2010203083A1Mutated structural protein of a parvovirusMEDIGENE AG·Filed 2008·Application pending·0 cites
- 3155US2018265514A1Salt of cd80 antagonistMEDIGENE AG·Filed 2017·Application pending·0 cites
- 3255US2010105123A2Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the sameMEDIGENE AG·Filed 2007·Application pending·0 cites
- 3354US7932253B2Immunomodulating oxopyrrazolocinnolines as CD80 inhibitorsMEDIGENE AG·Filed 2004·Granted Apr 26, 2011·0 cites·4 claims
- 3454US6562351B2Papilloma truncated L1 protein and fusion protein constructsMEDIGENE AG·Filed 2001·Granted May 13, 2003·10 cites·16 claims
- 3554US2010034796A1Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunctionMEDIGENE AG·Filed 2009·Application pending·0 cites
- 3653US7910138B2Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skinMEDIGENE AG·Filed 2004·Granted Mar 22, 2011·0 cites·16 claims
- 3753US2013288921A1Mutated parvovirus structural proteins as vaccinesMEDIGENE AG·Filed 2013·Application pending·0 cites
- 3852US6926897B1Medicament for the avoidance or treatment of papillomavirus-specific tumourMEDIGENE AG·Filed 2000·Granted Aug 9, 2005·0 cites·18 claims
- 3950US10408834B2Mutated parvovirus structural proteins as vaccinesMEDIGENE AG·Filed 2015·Granted Sep 10, 2019·0 cites·24 claims
- 4050US6171597B1Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cellsMEDIGENE AG·Filed 1997·Granted Jan 9, 2001·6 cites·10 claims
- 4150US2009317456A1Use of oncolytic viruses and antiangiogenic agents in the treatment of cancerMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4249US6448074B1Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cellsMEDIGENE AG·Filed 2000·Granted Sep 10, 2002·0 cites·10 claims
- 4347US2010297214A1Percolative drying for the preparation of particlesMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4447US2010316696A1Liposome preparation by single-pass processMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4546US6294370B1System for the production of AAV vectorsMEDIGENE AG·Filed 1997·Granted Sep 25, 2001·6 cites·22 claims
- 4646US2010034749A1Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular DiseasesMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4746US2011002851A1Cationic Colloidal Carriers for Delivery of Active Agents to the Blood-Brain Barrier in the Course of Neuroinflammatory DiseasesMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4843US2002039584A1Papilloma virus capsomere vaccine formulations and methods of useMEDIGENE AG·Filed 2001·Application pending·0 cites
- 4941US2011212072A1Inhibitors of Fatty Acid Oxidation for Prophylaxis and Treatment of Diseases Related to Mitochondrial DysfunctionMEDIGENE AG·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MEDIGENE AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →